OKYO PHARMA LIMITED ("OKYO" or "the Company") Interim Results - availability The OKYO Pharma Interim Report for the half-year ended 30 September 2022 (the "Interim Report") is available on the Company's website and can b
Tuesday, January 3, 2023 BiopharmaWatch Research 1 min read
Key Takeaway: OKYO Pharma Limited has made its Interim Report for the half-year ending September 30, 2022 available on its website and through the National Storage Mechanism. The report includes details regarding the company’s interim results, providing investors with transparency about its financial performance. Stakeholders can access the document online for further insights into the company's operations during this period.
Price reaction · baseline $1.91 (2022-12-30 close) · hit after-hours · clean, no other OKYO news in the window
day 0 close
+4.7%
day 1
+5.8%
day 3
-4.2%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+13%
120-day peak, hindsight
Typical move
9%
average across 7 past catalysts
Lead asset
OK-101
Phase 2 · Dry Eye Disease
Full Press Release Details
Results - availability
OKYO Pharma Interim Report for the half-year ended 30 September 2022 (the "Interim Report") is available on the Company's